Three more points about Paxlovid for covid-19

I would add three points to Extance’s overview of the oral antiviral combination of nirmatrelvir plus ritonavir (Paxlovid).1

Firstly, in the UK, Paxlovid is not currently authorised for use in children. The marketing authorisation states: “Paxlovid is indicated for the treatment of covid-19 in adults who do not require supplemental oxygen and who are at increased risk for progression to severe covid-19,” and, “The safety and efficacy of Paxlovid in paediatric patients younger …